Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...
Methotrexate by Pharmaceutical and Cosmetic Solutions for Rheumatoid Arthritis: Likelihood of Approval
Methotrexate is under clinical development by Pharmaceutical and Cosmetic Solutions and currently in Phase II for Rheumatoid Arthritis. According to...
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...